lovastatin has been researched along with Injuries, Radiation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anscher, MS; Chang, MG; Grob, BM; Holdford, D; Mikkelsen, RB; Moghanaki, D; Mukhopadhyay, ND; Rosu, M; Sanyal, A; Skinner, V; Wang, A | 1 |
| Fritz, G; Herzog, M; Hülsenbeck, J; Lackner, KJ; Ostrau, C; Schad, A; Torzewski, M | 1 |
| Fenton, B; Finkelstein, JN; Hernady, E; Johnston, CJ; Okunieff, P; Reed, CM; Williams, JP | 1 |
3 other study(ies) available for lovastatin and Injuries, Radiation
| Article | Year |
|---|---|
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anticholesteremic Agents; Case-Control Studies; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Lovastatin; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Radiation Injuries; Radiation Protection; Radiotherapy, Conformal; Rectum | 2018 |
Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo.
Topics: Animals; Cell Survival; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Radiation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Intestines; Liver; Lovastatin; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; Probability; Radiation Dosage; Radiation Injuries; Radiation Injuries, Experimental; Radiation, Ionizing; Random Allocation; Reference Values; RNA, Messenger; Tumor Necrosis Factor-alpha | 2009 |
Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model.
Topics: Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Lovastatin; Lung; Mice; Mice, Inbred C57BL; Radiation Dosage; Radiation Injuries; Respiration; Survival Rate | 2004 |